MXPA98010220A - Complex preparations characterized by beta content - Google Patents
Complex preparations characterized by beta contentInfo
- Publication number
- MXPA98010220A MXPA98010220A MXPA/A/1998/010220A MX9810220A MXPA98010220A MX PA98010220 A MXPA98010220 A MX PA98010220A MX 9810220 A MX9810220 A MX 9810220A MX PA98010220 A MXPA98010220 A MX PA98010220A
- Authority
- MX
- Mexico
- Prior art keywords
- compounds
- substances
- agents
- preparations
- preparations according
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 25
- 150000002500 ions Chemical class 0.000 claims abstract description 11
- 150000001875 compounds Chemical class 0.000 claims abstract description 8
- XUKUURHRXDUEBC-KAYWLYCHSA-N atorvastatin Chemical class C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-KAYWLYCHSA-N 0.000 claims abstract description 6
- 239000011230 binding agent Substances 0.000 claims abstract description 5
- 239000000853 adhesive Substances 0.000 claims abstract description 4
- 230000001070 adhesive Effects 0.000 claims abstract description 4
- 239000003212 astringent agent Substances 0.000 claims abstract description 3
- KWIUHFFTVRNATP-UHFFFAOYSA-N Trimethylglycine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 20
- 239000000126 substance Substances 0.000 claims description 11
- 229960003237 betaine Drugs 0.000 claims description 10
- 150000001413 amino acids Chemical class 0.000 claims description 8
- -1 astringent Chemical class 0.000 claims description 6
- 230000003212 lipotrophic Effects 0.000 claims description 5
- 239000003921 oil Substances 0.000 claims description 5
- 235000019198 oils Nutrition 0.000 claims description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 4
- 102000004169 proteins and genes Human genes 0.000 claims description 4
- 108090000623 proteins and genes Proteins 0.000 claims description 4
- 239000003925 fat Substances 0.000 claims description 3
- 235000019197 fats Nutrition 0.000 claims description 3
- 239000004094 surface-active agent Substances 0.000 claims description 3
- 239000000080 wetting agent Substances 0.000 claims description 3
- DSSYKIVIOFKYAU-UHFFFAOYSA-N Camphor Chemical compound C1CC2(C)C(=O)CC1C2(C)C DSSYKIVIOFKYAU-UHFFFAOYSA-N 0.000 claims description 2
- 229960000846 Camphor Drugs 0.000 claims description 2
- 241000723346 Cinnamomum camphora Species 0.000 claims description 2
- 239000004166 Lanolin Substances 0.000 claims description 2
- 229940039717 Lanolin Drugs 0.000 claims description 2
- 229920002472 Starch Polymers 0.000 claims description 2
- VXMKYRQZQXVKGB-CWWHNZPOSA-N Tannin Chemical compound O([C@H]1[C@H]([C@@H]2OC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)O[C@H]([C@H]2O)O1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 VXMKYRQZQXVKGB-CWWHNZPOSA-N 0.000 claims description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K [O-]P([O-])([O-])=O Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 239000000022 bacteriostatic agent Substances 0.000 claims description 2
- 229930007890 camphor Natural products 0.000 claims description 2
- 239000004202 carbamide Substances 0.000 claims description 2
- 229960000539 carbamide Drugs 0.000 claims description 2
- 235000013877 carbamide Nutrition 0.000 claims description 2
- 239000000975 dye Substances 0.000 claims description 2
- 239000000499 gel Substances 0.000 claims description 2
- 229910052742 iron Inorganic materials 0.000 claims description 2
- 235000019388 lanolin Nutrition 0.000 claims description 2
- 239000001525 mentha piperita l. herb oil Substances 0.000 claims description 2
- 239000001814 pectin Substances 0.000 claims description 2
- 235000010987 pectin Nutrition 0.000 claims description 2
- 229920001277 pectin Polymers 0.000 claims description 2
- 235000019477 peppermint oil Nutrition 0.000 claims description 2
- 235000019271 petrolatum Nutrition 0.000 claims description 2
- 239000010452 phosphate Substances 0.000 claims description 2
- 239000010671 sandalwood oil Substances 0.000 claims description 2
- 235000019698 starch Nutrition 0.000 claims description 2
- 235000018553 tannin Nutrition 0.000 claims description 2
- 229920001864 tannin Polymers 0.000 claims description 2
- 239000001648 tannin Substances 0.000 claims description 2
- 229910052718 tin Inorganic materials 0.000 claims description 2
- ATJFFYVFTNAWJD-UHFFFAOYSA-N tin hydride Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 claims description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 2
- 239000000341 volatile oil Substances 0.000 claims description 2
- 239000001993 wax Substances 0.000 claims description 2
- 150000007513 acids Chemical class 0.000 claims 2
- 229940116904 ANTIINFLAMMATORY THERAPEUTIC RADIOPHARMACEUTICALS Drugs 0.000 claims 1
- 241000196324 Embryophyta Species 0.000 claims 1
- 229940074726 OPHTHALMOLOGIC ANTIINFLAMMATORY AGENTS Drugs 0.000 claims 1
- 239000002260 anti-inflammatory agent Substances 0.000 claims 1
- 239000003429 antifungal agent Substances 0.000 claims 1
- 235000015110 jellies Nutrition 0.000 claims 1
- 239000000419 plant extract Substances 0.000 claims 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 claims 1
- 230000000843 anti-fungal Effects 0.000 abstract description 2
- 230000003110 anti-inflammatory Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 description 12
- 210000003491 Skin Anatomy 0.000 description 8
- 230000035790 physiological processes and functions Effects 0.000 description 8
- 210000001519 tissues Anatomy 0.000 description 8
- 239000000463 material Substances 0.000 description 7
- 229940029983 VITAMINS Drugs 0.000 description 6
- 229940021016 Vitamin IV solution additives Drugs 0.000 description 6
- 235000001014 amino acid Nutrition 0.000 description 6
- 230000003915 cell function Effects 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 230000004089 microcirculation Effects 0.000 description 6
- 235000013343 vitamin Nutrition 0.000 description 6
- 239000011782 vitamin Substances 0.000 description 6
- 229930003231 vitamins Natural products 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 230000003204 osmotic Effects 0.000 description 5
- 210000000689 upper leg Anatomy 0.000 description 5
- 210000004027 cells Anatomy 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 230000035876 healing Effects 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 230000000451 tissue damage Effects 0.000 description 3
- 231100000827 tissue damage Toxicity 0.000 description 3
- 241000282412 Homo Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 210000002381 Plasma Anatomy 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000019522 cellular metabolic process Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 238000009499 grossing Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 229940024606 Amino Acids Drugs 0.000 description 1
- 229940064005 Antibiotic throat preparations Drugs 0.000 description 1
- 229940083879 Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE Drugs 0.000 description 1
- 229940042052 Antibiotics for systemic use Drugs 0.000 description 1
- 229940019746 Antifibrinolytic amino acids Drugs 0.000 description 1
- 229940042786 Antitubercular Antibiotics Drugs 0.000 description 1
- 229960005261 Aspartic Acid Drugs 0.000 description 1
- 210000000170 Cell Membrane Anatomy 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 229960001231 Choline Drugs 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229960002449 Glycine Drugs 0.000 description 1
- 229940093922 Gynecological Antibiotics Drugs 0.000 description 1
- 229940021015 I.V. solution additive Amino Acids Drugs 0.000 description 1
- 210000001503 Joints Anatomy 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 230000036740 Metabolism Effects 0.000 description 1
- 210000003205 Muscles Anatomy 0.000 description 1
- 206010049752 Peau d'orange Diseases 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 229940066842 Petrolatum Drugs 0.000 description 1
- 210000004761 Scalp Anatomy 0.000 description 1
- 229940024982 Topical Antifungal Antibiotics Drugs 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940121375 antifungals Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 230000003115 biocidal Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000001413 cellular Effects 0.000 description 1
- 230000033077 cellular process Effects 0.000 description 1
- 230000036232 cellulite Effects 0.000 description 1
- CRBHXDCYXIISFC-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CC[O-] CRBHXDCYXIISFC-UHFFFAOYSA-N 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 150000001887 cortisones Chemical class 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 201000010251 cutis laxa Diseases 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 201000009910 diseases by infectious agent Diseases 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol group Chemical group OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 230000002489 hematologic Effects 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229940079866 intestinal antibiotics Drugs 0.000 description 1
- 159000000014 iron salts Chemical class 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 150000002696 manganese Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000002503 metabolic Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000035786 metabolism Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 230000000813 microbial Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229940005935 ophthalmologic Antibiotics Drugs 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002335 preservative Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002035 prolonged Effects 0.000 description 1
- 230000001624 sedative Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 231100000486 side effect Toxicity 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000002195 synergetic Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 239000011135 tin Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N β-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
Abstract
Preparations, specifically for local use, containing compounds containing ions, astringents, binders and adhesives, possibly lipotropic compounds, antifungal, anti-inflammatory and plant components, characterized by a beta-containing content
Description
COMPLEX PREPARATIONS CHARACTERIZED BY BETAINE CONTENT
DESCRIPTIVE MEMORY -r
The invention relates to complex preparations for local, intracorporeal or oral treatment that affects, maintains and improves cellular function, cellular metabolism, physiological processes, microcirculation, immunity, biostasis and / or prevention, healing, care of various manifestations of tissue damage, tissue change and deformation caused by exogenous and / or endogenic factors, or arising due to them, in humans and animals. It is known that there are already agents and preparations for treating and / or improving cell function, physiological processes or immunity. It is also known that there are local agents for the stimulation of the surface of the blood circulation and for the healing and care of the human and animal body. The bases of these agents, especially when dermal agents are involved, are usually antibiotics, cortisones, antifungals and other often very dangerous materials. Due to side effects, these are contraindicated, for example during pregnancy or for infants. These agents are also associated with other disadvantages because, if they are effective in any way, they are therapeutically effective only after prolonged use or when used in connection with other agents, or with a special diet. None of these known agents contain ionic preparations, which can introduce, at high osmotic pressure, the physiologically necessary materials, such as substances containing amino acids, enzymes,
• * mineral substances, vitamins, etc., inside cells and blood plasma due to its effect on the cell membrane. It is an object of this invention to provide preparations with natural materials on a phytobiological basis, especially for local use for rapid, effective treatment that affects and maintains cellular function, cellular metabolism, physiological processes, microarticulation, immunity, resistance , homeotasis and / or prevention, cure, care of various manifestations of tissue damage, changes and tissue deformation, caused by exogenous and / or endogenic influences or arising due to these, in humans and animals, which, at high osmotic pressure, carry the ions and the active ingredients to the cellular layer, selectively make the membrane porous and enter inside the cells and the blood plasma and, with the necessary substances, mineral materials, amino acids, enzymes, vitamins, proteins, acid and / or other components, provide and contribute significantly to reinforce and boost the processes physiological to establish the balance in the organism.
This object is achieved in accordance with the principles of the invention. It is known in the prior art (DE patent 3816442 C2) a local agent for the treatment of tissue and microbial tissue damage. In addition, the United Kingdom patent application no.2
106 386 relates to a preparation for the treatment of the scalp and hair containing a mixture of metals (especially iron salts, magnesium salts, manganese salts, calcium salts, zinc salts and copper salts), phosphates , carbohydrates, amino acids, vitamins and oils. The invention is based on special compositions of the preparations. The preparations according to the invention comprise compounds containing ions, salts, astringent components, amphoteric surfactants, wetting agents, binding agents and adhesives, essential oils, to which one or more materials may be added, if necessary. appropriate, such as enzymes, vitamins, proteins and auxiliary components. The preparations according to the invention are characterized not only by the presence of compounds containing ions, but also by the presence of lipotropic active agents, preferably betaine. Compounds containing ions and salts with Na, K, Mg, Ca and phosphate are preferred; the preferred astringents are tannin, aspartic acid and / or sandalwood oil; a preferred wetting agent is glycerin and a preferred ether oil is peppermint oil. Preferred binding agents preferably include pectin and / or a hydrogel such as agar gel. The preparations according to the invention have a comparatively low or physiologically normal pH value and a comparatively high osmotic pressure. The combined components according to the invention have a surprisingly effective synergistic effect whereby cell function, metabolism, physiological processes and microcirculation are promoted, while simultaneously supplying and supplying to all tissues important substances, such as as mineral substances, amino acids, dextrose, enzymes, vitamins and proteins, which is especially advantageous in the case of physical exertion and altered physiological balance. If necessary, the preparations according to the invention may contain, among other ingredients, vegetable extracts, emulsifiers, amino acids, lanolin, glycine, choline, eucerin, dyes, waxes, bacteriostatic agents, oils, starches, tin, iron, fats, gelatins, preservatives, petrolatum, camphor, carbamide, surfactants, paraffins. The amount of the components is variable and can be 0.01% for one component and 20% more for another. The examples that are provided explain this more widely.
In its consistency or administration, the preparations according to the invention can be an infusible and / or local solution, ointment, cream, gel, lotion, powder, sprayer, foam, emulsion, tablets, capsules, textile wound dressings or can be mixed partially or completely with other agents or other materials. In the preparations according to the invention, the amounts provided can be increased or decreased and / or the components can be omitted and / or exchanged. The preparations according to the invention vary in their decomposition and the principle and effect resulting from their function, period of effect, methods of use, interaction and availability as do other comparable agents of the prior art, especially agents that are for local use. to affect, boost, maintain and / or restore cellular function, physiological processes, microcirculation, immunity in human or animal tissue. As a lipotropic active ingredient, betaine is known as a component in the production of sedatives, surfactants, body cleansers to inhibit infections. But it should be considered as very surprising that the betaine reaches the deep cell level with the lipotropic substance containing amino acids in preparations containing ions according to the invention via high-pressure osmotic ions and produces an exchange of cells and nutrients intensely high, and an improved microcirculation and extensive physiological processes. It should be considered as very surprising that, only in the preparations indicated according to the invention, betaine effectively reaches the deep tissue and manifests an effective influence of cellular and physiological processes. It should be considered as surprising that effective substances, such as betaine, but also enzymes, vitamins and other essential materials and elements, can be rapidly and precisely administered locally via the preparations containing ions according to the invention. and avoid osmotic pressure. The ionic results confirm these surprising effects and show a significantly improved microcirculation and improved and increased physiological processes, which are manifested especially in the tissues of the skin and muscles, fibers, joints and healing processes. These surprising results can also offer new advantages and opportunities in the immunological, hematological and metabolic fields. The surprising effect of the betaine-containing compounds according to the invention was confirmed by the following clinical tests: 15 individuals, female, aged 20-58, were divided into three groups of five each (A, B and C). All individuals exhibited a characteristic manifestation of cellulitis in the second stage or third in the thigh: test with positive forceps, mattress-shaped protuberances visible to the naked eye when standing
(according to the stage) or when they were lying down as well as when they were standing (third stage), loose skin tone. These symptoms are the result of interrupted, deficient cellular function and microcirculation, which results in the accumulation of water and fat in the tissue. During the trial period it was required that the individuals did not change anything about their lifestyle and that they did not start any diet or aerobic / sports activities. Group A applied the ion-containing preparation according to the invention to the affected skin area (right thigh) once a day for 14 days, applying it in a thin layer and massaging it into the skin until it was completely absorbed. . The circumference of the thigh was measured in a place marked on the first day and the last day of the treatment. The stretching and smoothing of the skin was visible already after four days. After eight days of. treatment, you could observe a clearly visible reduction of the pertuberance on the surface of the skin. After 14 days, the surface of the treated skin was smooth, flexible, elastic and stretched. A reduction in thigh circumference of up to 3 cm was measured in all five individuals. Group B underwent the same treatment with a preparation that contained ions such as group A, but without the inclusion of betaine. After about ten days, light smoothing and stretching of the skin was confirmed in four of the five individuals. However, after the fourteen day treatment, there were no more changes or improvements in the manifestation of cellulite. Group C underwent the same treatment of a body cleansing agent that contained betaine. After fourteen days, none of the individuals showed an improvement or a positive change, either in the condition of the skin or in the circumference of the thigh.
EXAMPLE 1
EXAMPLE 2
EXAMPLE 3
EXAMPLE 4
EXAMPLE 5
EXAMPLE 6
Claims (4)
1. - Complex preparations containing the following components: a) one or more compounds containing ions and lipotropic substances, b) an astringent agent, a binding agent and adhesive, a wetting agent and one or more essential oils, c) if necessary amino acids , proteins, antifungal agents, anti-inflammatory agents, plants and other components necessary for the purpose of the invention, characterized by a betaine content.
2. - Preparations according to claim 1, further characterized in that component a) contains compounds of Na-, K-, Cl-, Mg-, Ca, and phosphate and at least one of these compounds.
3. Preparations according to claims 1 and 2, further characterized in that component b) contains tannin or an acidic compound such as astringent, pectin or a gel as binder and adhesive, peppermint oil as ether oil, or at least one of these components.
4. - Preparations according to claims 1, 2 and 3, further characterized in that component c) contains, if necessary, substances containing amino acids, substances that contain. acids, lipotropic substances, bacteriostatic agents, lanolin, eucerin, plant extracts, waxes, dyes, oils, starches, tin, iron, sulphate compounds, jellies, fats, carbamide, surfactants, paraffins, petroleum jelly, sandalwood oil, camphor, or conservatives.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19622708.9 | 1996-06-05 | ||
DE196227089 | 1996-06-05 | ||
DE196482321 | 1996-11-21 | ||
DE19648232.1 | 1996-11-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA98010220A true MXPA98010220A (en) | 1999-06-01 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3917370B2 (en) | Skin and tissue protection and / or therapeutic agents | |
JP2002520348A5 (en) | ||
JP2002053428A (en) | Skin care preparation | |
CN111973481A (en) | Blue ketone peptide repair essence and preparation method thereof | |
EP0914138B1 (en) | Complex preparations characterised by a betain content | |
KR20230104550A (en) | Moisturizer | |
EP3634342A1 (en) | Silicone pad having active ingredients for skin care and against skin aging | |
RU2295951C1 (en) | Composition for face and eyelids skin care | |
DE202006019184U1 (en) | Moisturizing sea buckthorn skin care gel, useful to nourish and clean skin that is damaged by cancer therapy, comprises wax and fat; vitamin; vegetable hydrolate; moisturizing and anti-allergic active substance, pH-regulator and buffer | |
MXPA98010220A (en) | Complex preparations characterized by beta content | |
WO2017026698A1 (en) | Keratin softening patch | |
CN109199955B (en) | Water replenishing spray and preparation method thereof | |
JPS61246130A (en) | External agent for stimulation skin cell activity | |
RU2780260C1 (en) | Cosmetic for skin | |
RU2123320C1 (en) | Face cream "talita" | |
RU2186561C2 (en) | Cream for dry and normal face skin | |
EP0477833A1 (en) | Composition for therapeutic and/or cosmetic use for treatment of circulatory diseases and for aesthetic medicine treatments | |
CN116139050B (en) | Essence water with microcapsule coated with sea buckthorn seed oil and grape seed oil and preparation method thereof | |
DE19648232A1 (en) | Aqueous compositions containing betaine | |
DE1667890B2 (en) | DERMATOLOGICAL AND COSMETIC EXTERNAL PRODUCTS FOR THE TREATMENT OF SKIN COLLAGENOSE | |
RU2212229C1 (en) | Diurnal recovering cream | |
RU2195255C2 (en) | Cosmetic and dermatological remedy and method of skin and/or keratin materials treatment | |
CN114948770A (en) | Cosmetic ingredient formula for repairing skin lipid membrane damage | |
RU2151594C1 (en) | Ointment for prophylaxis and treatment of dermatological diseases of different etiology | |
KR20210012350A (en) | Artificial layer cream composition having superior moisture retention and skin penetration effect by nanoliposome treatment method |